1. Introduction
===============

Mechanical ventilation (MV) in PICU is a major therapeutic modality, and a major indication for PICU admission. The frequency of utilizing MV, according to previous studies, varies from 24--60% of all pediatric intensive care units (PICUs) ([@b1-epj-09-4370]--[@b4-epj-09-4370]). Two multicenter studies, the International Group for Mechanical Ventilation in Children (IGMVC) and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) have studied characteristics of pediatric patients on MV ([@b6-epj-09-4370], [@b7-epj-09-4370]). Pediatric patients on MV are the severest of cases requiring PICU admission. MV is employed for a variety of reasons and with different modes and variable outcomes. The extended knowledge of MV is valuable in various aspects; optimizing its use in critically sick children, and allocation of hospital resources as utilization rate determines the needed number of PICU beds ([@b5-epj-09-4370]). To our knowledge this is the first study to describe the characteristics of pediatric patients on MV in our country, which is important in intensifying training for its use and avoiding lethal complications. Our study aimed at assessing the reasons for using MV, clinical spectrum, different modes of ventilation, complications rate, risk factors of mortality and prognosis of sick children on MV in a Middle Eastern country.

2. Material and Methods
=======================

2.1. Design and setting
-----------------------

In this observational study, we prospectively followed the pediatric patients who were admitted to intensive care, at Cairo University Pediatric Hospital from January 2014 to December 2014, as two separate general intensive care units with 24 beds and 24 ventilators allocated to each bed collectively.

2.2. Instruments and procedures
-------------------------------

The mechanical ventilators which were available for this study were Newport 360E. Inclusion criteria were; children aged between 1 month to 18 years, and intubation for more than 12 hours. Subjects were excluded if they were intubated for less than 12 hours, neonates, and post-operative cardiothoracic patients. Hypoxemia was defined as PaO~2~\<50 and hypercapnia was defined as PaCO~2~\>50 mmHg. Subjects' data were collected including demographic data as age and sex, diagnosis, reason for initiation of MV, PRISM III, length of stay on MV from the time of initiation to the time of liberation, mode of MV used upon its initiation, complications, methods of weaning, the presence of sepsis and multiple organ dysfunction syndrome as a cause of mortality, and finally the outcome of the patients as survival or demise. Indications for MV were categorized into: acute hypoxemic respiratory failure e.g. pneumonia, neuromuscular disease (NMD) subjects developing pneumonia presenting as acute carbon dioxide retention on top of a chronic disease e.g. myopathy, or acute neuropathy as Guillian Barré Syndrome, acute cardiovascular failure, encephalopathy and sepsis. The access to the airway to most of our subjects was through endotracheal intubation (ETT); orotracheal tubes and a few with nasotracheal tubes and tracheostomy. The modes of MV mostly used were assist control pressure controlled ventilation AC/PCV, assist control volume controlled ventilation AC/VCV, synchronized intermittent mandatory ventilation (SIMV) either volume or pressure limited, pressure support (PS), or SIMV with PS. Other parameters were set according to the patient's condition as FIO~2~, PEEP, PIP, and VT. Monitoring the subjects on MV was done with daily ABG at 8:00 am and on demand, and oxygen saturation was continuously recorded thorough pulse oximeter. Chest X-ray was ordered upon initiation of MV and on demand. Nursing care for subjects on MV was ordered as clearance of endotracheal tube secretions on demand through open-circuit suction catheter. Strategies to prevent VAP were adapted; hand hygiene, elevation of the head of the bed at an angle of 30 degrees, mouth wash with antiseptics, and changing ventilator circuits when visibly soiled or once weekly if the patient stayed longer. Nurse to patient ratio was 1 to 3 throughout day and night, and that is due to the financial limitation of the institute in the face of the sizable number of referred subjects from all over the country. Chest physiotherapy is done routinely by a nurse and frequently with an experienced physiotherapist once daily. Subjects were followed by a consultant intensivist rather than a respiratory therapist. Subject weaning was initiated after improving clinical condition, criteria of extubation were, FIO~2~\<0 .4, oxygenation index \< 5, rapid shallow breathing index (RSBI) is not more than 100 and no accessory work of breathing with ABG analysis reading; pH \>7.3 PCO~2~, is 35--50 mmHg, PO~2~\>60 mmHg. The occurrence of multiple organ system dysfunction was recorded as one of the causes of mortality.

2.3. Definitions
----------------

VAP was diagnosed in patients on ventilation for more than 48 hours with a new persistent infiltrate, on chest radiograph and at least 3 of the following; fever, leucopenia or leukocytosis, increased sputum production, rales, cough or worsening gas exchange ([@b8-epj-09-4370]). ARDS was defined according to the new Berlin definition ([@b9-epj-09-4370]). The spontaneous breathing trial (SBT) was defined as lasting from 0.5 to 2 hours performed with either, PSV \< 10 cm H~2~O or a T-piece, or continuous positive airway pressure \< 5 cm H~2~O, before extubation ([@b10-epj-09-4370]). Sepsis was defined according to international consensus conference on pediatric sepsis ([@b11-epj-09-4370]). Organ function status was evaluated according to the score described by Marshall et al. Five organ dysfunctions (lung, liver, kidney, hemodynamic and consciousness) were scored daily from no dysfunction to four points (severe dysfunction). Failure of organ function was considered at three or more points ([@b12-epj-09-4370]).

2.4. Ethical considerations
---------------------------

The aim and nature of the study was explained for each parent before inclusion. An informed written consent was obtained from parents or caregivers before enrolment. The study design conformed to the requirements of the latest revision of the Helsinki Declaration of Bioethics ([@b13-epj-09-4370]). The Scientific Research Committee of Pediatrics Department-Faculty of Medicine - Cairo University revised and approved the study design.

2.5. Statistical analysis
-------------------------

Pre-coded data was entered into the IBM© SPSS© Statistics version 21 (IBM© Corp., Armonk, NY, USA) for data analysis. Data was summarized using range, mean, standard deviation and median with interquartile range (IQR) for quantitative variables, and frequency and percentage for qualitative ones. Comparison between groups was performed using a Mann Whitney test for quantitative variables and Chi square with Fisher's exact test for qualitative ones. Multivariate logistic regression model was conducted to explore the significant predictors for PICU mortality with logarithmic transformation of the quantitative variables to assume normality. The p-values less than 0.05 were considered statistically significant, and less than 0.01 were considered highly significant.

3. Results
==========

In 2014, there were 893 patients admitted to two pediatric intensive care units. Of the 893 patients, 293 were ventilated with invasive MV, making the incidence of mechanically ventilated children 32.8%. Clinical variables as age, sex, cause of mechanical ventilation whether surgical and medical, PRISM III score and duration of MV were presented in [Table 1](#t1-epj-09-4370){ref-type="table"} as median and interquartile range. Reasons for initiation of mechanical ventilation were neurological causes in 114 (38.9%) cases, respiratory causes in 71 (24.23%) cases, cardiovascular causes in 58 (19.8%) cases, safe airways in 34 (11.6%) cases, and neuromuscular causes in 16 (5.46%) cases. While the reasons for admission to intensive care were presented in [Table 2](#t2-epj-09-4370){ref-type="table"}: Neurological etiology in 101 cases, respiratory in 65 cases, cardiac in 54 cases, sepsis in 34 cases, NMD in 16 cases, renal in 6 cases, post-operative in 2 cases and other reasons in 15 cases. The access to airways were through endotracheal tubes in most cases, while 4 cases were tracheostomized (1.4%). Regarding the modes used at the initiation of mechanical ventilation, SIMV + PS mode, AC/PCV mode, AC/VCV, and PS were used in 49%, 29%, 13%, and 9% of cases respectively. Duration of mechanical ventilation ranged from 2--90 days (median 9 and IQR = 5--15). PaO~2~/FIO~2~ ratio was classified into 3 groups\< 200, 200--300 and \> 300. ARDS occurred in 26 (8.9%) cases. Complications occurred in 117 (39.9%) cases that is 29.5 per 1000 ventilation days, classified as the occurrence of VAP in 80 (27.3%) (20. 19/1000 ventilation), pneumothorax 31 (10.6%) (7.82/1000 ventilation days), atelectasis 13 (4.4%) (3.28/1000 ventilation), and post extubation stridor (PES) 7 (2.4%) (1.76/1000 ventilation). More than one complication occurred in 14/117 patients. Of the survived patients, eight were still not weaned till the study terminated. Methods of weaning were recorded in survived subjects, pressure support (PS) with CPAP in 115/154 (74.7%) of cases, CPAP alone in 20 (12.9%), t-tube in 11 (7.1%) and unplanned accidental extubation in 8 (5.1%). The occurrence of multiple organ dysfunction syndrome (MODS) was reported in 121 (41.3%). Mortality occurred in 131/293 (44.7%) of ventilated patients. Causes of mortality were sepsis in 53 cases (40.5%), intractable heart failure in 33 (25.2%), ARDS in 28 (21.4%), brain death in 14 (10.7%) and hepatic failure in 3 (2.3%). Duration of mechanical ventilation was significantly longer in NMD (41.1 ± 33.9 with median 28.5) (p 0.001), and with the occurrence of complications (20.8 ± 17.8 with median 16) (p \< 0.001). Expired patients stayed less on MV than survived ones (p \< 0.001). Higher mortality rates were significantly related to higher PRISM III score 18.6 ± 12.1, cardiovascular cases, with sepsis, lower PaO~2~/FIO~2~ ratio \< 200 and 200--300, MODS, and with the occurrence of barotrauma and VAP. While lower mortality rates occurred with respiratory cases ([Table 3](#t3-epj-09-4370){ref-type="table"}). Multivariate logistic regression model was conducted to explore the significant predictors for PICU mortality. Both PRISM score and MV duration were subjected for logarithmic transformation to assume normality, R^2^ = (0.585--0.782), the only significant predictors were presence of complications, MODS, PRISM III on admission and MV duration ([Table 4](#t4-epj-09-4370){ref-type="table"}).

4. Discussion
=============

This study is the first study to address the practice of MV in pediatric intensive care in an Egyptian university hospital. Studies were performed elsewhere; in USA, Canada, Italy and other countries, to investigate the use of MV in their PICUs ([@b2-epj-09-4370], [@b3-epj-09-4370], [@b5-epj-09-4370], [@b17-epj-09-4370]), however we have different subjects' characteristics and different risk factors added to the limited financial resources. The majority of our patients are of low socioeconomic backgrounds; in addition, they are referred to our center in a rather late stage of diseases that adds to the complexity of their disease. The incidence of utilizing mechanical ventilation in our units is 32.8%. Other published studies reported incidence rate of MV utilization 35%--64% ([@b4-epj-09-4370], [@b6-epj-09-4370], [@b7-epj-09-4370]). In the present study, neurologic causes were the most frequent reason of ventilation 144 (38.9%). Other studies reported a high incidence of neurologic causes for MV; 32 and 36% in less developed countries ([@b1-epj-09-4370], [@b3-epj-09-4370]). These results contrasted with other published studies on pediatric subjects, as the most common indications were respiratory causes that represented 60%--75% of ventilated subjects ([@b4-epj-09-4370], [@b6-epj-09-4370], [@b7-epj-09-4370], [@b14-epj-09-4370]--[@b16-epj-09-4370]). This can be explained by being a tertiary care hospital, most cases referred to us are severe and complicated neurologic cases. Most respiratory cases are treated at their local hospitals. Also, the warm climate all year round except January and February months which are cold winter months, explains the low incidence of viral respiratory infections. The most common mode of ventilation used initially was pressure control with SIMV and PS (49% of cases). Harel et al. reported that the preferred mode for initiating the MV in infants and children was SIMV with a percentage ranging from 65% to 82%, followed by PCV (2--17%) ([@b17-epj-09-4370]). MV use is not without complication. It can no longer be viewed simply as a harmless modality deployed to support the subject while disease-specific treatments are used to treat the underlying pathology ([@b18-epj-09-4370]). Those complications may prolong the duration of MV itself, or the overall duration of hospitalization, or increase subject mortality ([@b19-epj-09-4370]). Complication occurred in 117 (39.9%) cases, subjects with VAP had the highest incidence with 80 cases (27.3%) accounting for 20.19 per 1000 ventilation days. These results were similar to the results obtained by Principi and co-workers who found a complication rate of 40% in mechanically ventilated children; however, atelectasis was the most common complication found in 16.7% of cases in the Principi study ([@b19-epj-09-4370]). Unfortunately, the incidence of VAP in our units is still very high, although we are trying to endorse VAP bundle, still there is a missing link with our low-staffed units and the absence of infection control personnel monitoring during night shifts.

Ratio of VAP was high in our study compared to the incidence of VAP in high-income countries; (2.1--5.5 per 1,000 days) according to NNIS and INNIC surveillance data ([@b20-epj-09-4370]). While Elward and co-workers recorded VAP incidence of 11.6/1000 ventilator days ([@b21-epj-09-4370]). In children SBTs in pediatrics have been shown to be feasible and to have a high sensitivity for predicting extubation success ([@b22-epj-09-4370]). SBT with pressure support mode of weaning is the preferred method of weaning in our practice, used in 115/154 (74.7%) of survived subjects. ARDS came in third place as a cause of mortality occurring in 28 (21.4%), which was lower than other studies. ARDS, as a cause of mortality in MV children was found to be 32%--36.5% in two European studies ([@b23-epj-09-4370], [@b24-epj-09-4370]), while this ratio was doubled in an Asian study to reach 60% ([@b25-epj-09-4370]). We have found mortality rate to be (44.7%) in our study and this mortality was significantly higher with higher PRISM III, MODS, cardiovascular cases, barotraumas, occurrence of VAP, and ARDS, while respiratory cases had the lowest mortality. According to the age groups, infants less than 1 year had the higher mortality than older age groups; 71/131 (54.2%), however it was not statistically significant (p=0.6). Multivariate logistic regression model was conducted, R^2^ = (0.393 -- 0.526), the only significant predictors were presence of MODS, PRISM III score. Reported mortality of children on MV in developed countries were 1.6 -- 15% ([@b4-epj-09-4370], [@b5-epj-09-4370], [@b7-epj-09-4370], [@b26-epj-09-4370]), while mortality rate was higher in less developed countries 30--3% -- 58.3% ([@b3-epj-09-4370], [@b17-epj-09-4370]). Prognosis of mechanically ventilated children was reported to be related to high PRISM score, and the presence of MODS in other studies ([@b26-epj-09-4370], [@b27-epj-09-4370]). Regarding the limitation of the study, the study did not include arterial blood gases (ABGs) parameters, or ventilator setting changes used in the study according to ABGs.

5. Conclusions
==============

MV is frequently deployed in PICU practice. Most children are ventilated due to neurologic causes. The most common mode of ventilation is pressure control with SIMV and PS, while the weaning mode of choice is PS with CPAP. Mortality rate was high and correlated with higher PRISM III score and MODS. We believe that this study described our employment of ventilation in Egypt adequately in one of its biggest pediatric hospitals, and that pediatric intensivists still cling to conventional modes of ventilation, and decline to use newer modes. We recommend extensive training of the physicians and nurses to decrease complications rate.
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###### 

Clinical characteristics of patients

  Variable                                                                                                                                                        
  --------------------------------------------------------------------------------- ----------------------------------------------------------------------------- -------------------
  Age                                                                               Age (in months, median and IQR[\*](#tfn1-epj-09-4370){ref-type="table-fn"})   1--144 (8, 5--36)
  Less than 1 year; n (%)                                                           135 (52.2%)                                                                   
  1--6 years; n (%)                                                                 107 (36.5%)                                                                   
  6--12 years; n (%)                                                                33 (11.3%)                                                                    
  Sex                                                                               Males, n (%)                                                                  162 (55.3%)
  Females; n (%)                                                                    131 (44.7%)                                                                   
  PRISM III (median, IQR)                                                           10 (6 -- 20)                                                                  
  Cause of admission                                                                Medical n (%)                                                                 269 (91.8%)
  Surgical n (%)                                                                    24 (8.2%)                                                                     
  MV[†](#tfn2-epj-09-4370){ref-type="table-fn"} duration (median in days and IQR)   9 (5.0 -- 15)                                                                 

interquartile range;

MV mechanical ventilation

###### 

Reasons for admission to intensive care

  Reason for admission                                             Sub classification      n      Subtotal %   Total %
  ---------------------------------------------------------------- ----------------------- ------ ------------ ---------
  Neurological (n=101)                                             Coma                    21     20.8         7.1
  Encephalitis                                                     19                      18.8   6.4          
  Status epilepticus                                               17                      16.8   5.7          
  ICH[\*](#tfn3-epj-09-4370){ref-type="table-fn"}                  12                      11.9   4.1          
  Apnea                                                            9                       8.9    3.0          
  Stroke                                                           6                       5.9    2.0          
  Obstructed VP[†](#tfn4-epj-09-4370){ref-type="table-fn"} shunt   5                       5.0    1.7          
  Brain tumor                                                      3                       3.0    1.0          
  IEM[‡](#tfn5-epj-09-4370){ref-type="table-fn"}                   4                       4.0    1.4          
  TBI[§](#tfn6-epj-09-4370){ref-type="table-fn"}                   3                       3.0    1.0          
  Brain abscess                                                    2                       2.0    0.7          
  Respiratory (n=65)                                               Pneumonia               45     69.2         15.4
  Bronchiolitis                                                    15                      23.1   5.1          
  FB[\|\|](#tfn7-epj-09-4370){ref-type="table-fn"} inhalation      3                       4.6    1.0          
  Bronchial asthma                                                 2                       3.1    0.7          
  Cardiac (n=54)                                                   Shock                   21     38.9         7.2
  CHD[¶](#tfn8-epj-09-4370){ref-type="table-fn"}                   18                      33.3   6.1          
  Cardiomyopathy                                                   15                      27.8   5.1          
  Sepsis (n=34)                                                    Sepsis                  34     100.0        11.6
  NMD (n=16)                                                       Spinal muscle atrophy   8      50.0         2.7
  Congenital myopathy                                              4                       25.0   1.4          
  [\*\*](#tfn9-epj-09-4370){ref-type="table-fn"}GBS                2                       12.5   0.7          
  Neiman pick disease                                              2                       12.5   0.7          
  Renal (n=6)                                                      Renal failure           6      100.0        2.0
  Post-operative (n=2)                                             Post-operative          2      100.0        0.7
  Others (n=15)                                                    Toxic                   8      53.3         2.7
  Hepatic                                                          5                       33.3   1.7          
  Rheumatologic                                                    2                       13.3   0.7          

ICH: intracranial haemorrhage,

VP: ventriculoperitoneal,

IEM: inborn error of metabolism,

TBI: traumatic brain injury,

FB: foreign body,

CHD: congenital heart disease,

GBS: Guillian Barré Syndrome

###### 

Relationship of outcome to various characteristics

  Variable                                                Outcome             *p* -value[\*](#tfn10-epj-09-4370){ref-type="table-fn"}                                 
  ------------------------------------------------------- ------------------- --------------------------------------------------------- ----------- --------- ------- ---------
  Age (months)                                            Mean ± SD           28.0±35.2                                                 26.5±33.8   0.3               
  Median                                                  8.0                 9.0                                                                                     
  Age groups n (%)                                        \< 1 year           71                                                        54.2        82        50.6    0.6
  1 -- 6 years                                            44                  33.6                                                      63          38.9      0.4     
  \> 6 years                                              16                  12.2                                                      17          10.5      0.7     
  Sex n (%)                                               Male                69                                                        52.7        93        57.4    0.5
  Female                                                  62                  47.3                                                      69          42.6              
  PRISM III on admission                                  Mean ± SD           23.7±11.6                                                 8.2±3.9     \<0.001           
  Median                                                  20.0                8.0                                                                                     
  Cause n (%)                                             Medical             118                                                       90.1        151       93.2    0.4
  Surgical                                                13                  9.9                                                       11          6.8               
  Reason for admission n, %                               Neurological        40                                                        30.5        61        37.7    0.2
  Respiratory                                             19                  14.5                                                      46          28.4      0.005   
  Cardiac                                                 33                  25.2                                                      21          13.0      0.010   
  Sepsis                                                  24                  18.3                                                      10          6.2       0.002   
  Neuromuscular disease                                   4                   3.1                                                       12          7.4       0.1     
  Renal                                                   4                   3.1                                                       2           1.2       0.4     
  Post-operative                                          0                   0.0                                                       2           1.2       0.5     
  Others                                                  7                   5.3                                                       8           4.9       1.0     
  Reason for initiation of ventilation n, %               Neurologic          47                                                        35.9        67        41.4    0.4
  Respiratory failure                                     19                  14.5                                                      52          32.1      0.001   
  Cardiovascular failure                                  37                  28.2                                                      21          13.0      0.002   
  Sepsis                                                  24                  18.3                                                      10          6.2       0.002   
  Neuromuscular                                           4                   3.1                                                       12          7.4       0.1     
  FIO~2~/PaO~2~ n (%)                                     \< 200              59                                                        45.0        51        31.5    0.02
  200--300                                                38                  29.0                                                      78          48.1      0.001   
  \> 300                                                  34                  26.0                                                      33          20.4      0.3     
  ARDS n, %                                               Yes                 19                                                        14.5        7         4.3     0.003
  No                                                      112                 85.5                                                      155         95.7              
  Airways n, %                                            Endotracheal tube   131                                                       100.0       158       97.5    0.1
  Tracheostomy                                            0                   0.0                                                       4           2.5               
  Mechanical ventilation duration n, %                    Mean ± SD           8.5±6.9                                                   17.5±19.5   \<0.001           
  Median                                                  7.0                 10.0                                                                                    
  Complications n, %                                      Yes                 64                                                        48.9        53        32.7    0.006
  No                                                      67                  51.1                                                      109         67.3              
  VAP[†](#tfn11-epj-09-4370){ref-type="table-fn"} (%)     Yes                 47                                                        35.9        33        20.4    0.004
  No                                                      84                  64.1                                                      129         79.6              
  Pneumothorax n, %                                       Yes                 19                                                        14.5        12        7.4     0.06
  No                                                      112                 85.5                                                      150         92.6              
  Atelectasis n, %                                        Yes                 3                                                         2.3         10        6.2     0.2
  No                                                      128                 97.7                                                      152         93.8              
  PES[‡](#tfn12-epj-09-4370){ref-type="table-fn"} n, %    Yes                 3                                                         2.3         4         2.5     1.0
  No                                                      128                 97.7                                                      158         97.5              
  MODS[§](#tfn13-epj-09-4370){ref-type="table-fn"} n, %   Yes                 98                                                        74.8        23        14.2    \<0.001
  No                                                      33                  25.2                                                      139         85.8              

*p* value less than 0.05 is significant,

VAP: ventilator-associated pneumonia,

PES: post extubation stridor,

MODS: multiple organ dysfunction syndrome

###### 

Multivariate logistic regression model

  Variables                                      *p*-value   OR      95% CI of OR   
  ---------------------------------------------- ----------- ------- -------------- --------
  Female sex                                     0.068       2.365   0.939          5.956
  Cardiovascular as a reason for MV initiation   0.891       0.924   0.298          2.863
  Respiratory as a reason for MV initiation      0.149       0.410   0.122          1.377
  Sepsis as a reason for MV initiation           0.118       0.277   0.055          1.387
  Presence of complications                      0.002       4.823   1.761          13.206
  MODS                                           \<0.001     8.711   3.077          24.660
  PRISM III on admission                         \<0.001     1.406   1.260          1.568
  MV duration                                    0.008       0.909   0.846          0.976
